How common are headaches on Wegovy
Headache rates varied across the STEP clinical trial programme.
They were moderately more common than placebo in the first year but resolved to normal levels by year two.
| Trial |
Semaglutide 2.4 mg |
Placebo |
Duration |
| STEP 1 (Wilding et al., 2021)2 |
~14% |
~10% |
68 weeks |
| STEP 5 (Garvey et al., 2022)3 |
10.5% |
10.5% |
104 weeks |
By year 2, headache rates were identical in both groups, indicating that the medication-related excess seen in shorter trials doesn’t persist long term.3
Headaches are also far less common than the gastrointestinal side effects of Wegovy.
When analysing the results of multiple studies on Wegovy, nausea affected around 44% of people and vomiting around 25%, compared to 14% for headaches.5
Tirzepatide (Mounjaro) shows broadly similar headache rates to semaglutide, although gastrointestinal side effects tend to be slightly more common with tirzepatide.
Why Wegovy can cause headaches
Most headaches on Wegovy come from indirect effects rather than the drug acting directly on the brain.
Dehydration
Dehydration is the most common cause. Wegovy’s gastrointestinal side effects (nausea, vomiting, diarrhoea) can lead to fluid loss.
Reduced appetite can also mean you drink less without realising it.
Dehydration headaches are typically dull and aching, affect both sides of the head, and improve when you drink water.
Changes in eating patterns
When your appetite drops on Wegovy, it’s easy to skip meals or eat much less than usual.
Your brain relies on a steady supply of energy from food, and significant changes in calorie intake can trigger headaches.
Eating regular, smaller meals rather than skipping food altogether helps keep blood sugar stable and reduces this risk.
Blood sugar fluctuations
Semaglutide enhances insulin secretion only when blood sugar is rising, so the risk of true low blood sugar is low when Wegovy is used on its own.1
However, rapid changes in eating patterns can still cause blood sugar fluctuations that trigger headaches, particularly in the first few weeks.
Caffeine withdrawal
If nausea makes coffee or tea less appealing in the first few weeks, you may reduce your caffeine intake without noticing.
Cutting back by even one or two cups of coffee a day can be enough to trigger a withdrawal headache, typically within a day or two of reducing intake.
If you’re cutting back on caffeine, do it gradually over a week or two rather than stopping suddenly, and drink extra water during this period.
Sleep changes
Some people report changes in sleep during the first few weeks on Wegovy, including vivid dreams, lighter sleep, or waking up due to nausea.
Poor sleep is a well-known headache trigger, so keeping consistent sleep and wake times during dose increases can help.
Direct effects on the brain
The brain has a protective barrier that keeps most medications out.
Semaglutide doesn’t cross this barrier, but it does reach a few specific areas where the barrier is naturally more open, including parts of the brainstem and hypothalamus that control appetite and nausea.
Wegovy works by activating GLP-1 receptors, which are concentrated in some of these brain regions, including parts of the brainstem and hypothalamus involved in appetite and nausea.
Even within these limited brain regions, the way GLP-1 receptors influence appetite, nausea, and gut motility can produce knock-on effects that some people experience as a headache.
This same pathway is being investigated as a potential treatment for migraine and a condition called idiopathic intracranial hypertension, where preliminary studies have shown promising results in reducing headache frequency.4
If you already get migraines
If you already experience migraines, you may notice some changes during the first few months on Wegovy.
Some people report a temporary increase in migraine frequency during dose increases, likely linked to dehydration and changes in meal patterns.
Others find their migraines improve over time as they lose weight, since obesity itself is a risk factor for chronic migraine.
Keep your usual migraine prevention plan in place when starting Wegovy. If your migraines worsen significantly or change in character, speak to your GP or neurologist.
Preventing and managing headaches
Stay well hydrated
Drink water regularly throughout the day, even when you don’t feel thirsty.
If nausea makes large glasses of water unappealing, try small, frequent sips.
Ginger tea, water with lemon, or naturally flavoured water can help if plain water is difficult to drink.
Watch for signs of dehydration: dark urine, dry mouth, dizziness, or fatigue. These are cues to increase your fluid intake.
Eat regular meals
Even if your appetite is reduced, try to eat something at regular intervals.
We recommend aiming for 3 balanced meals a day, plus protein-rich snacks in between if needed.
Including protein at each meal (eggs, chicken, fish, lentils, tofu) helps maintain steady blood sugar levels and reduces the risk of headaches from energy dips.
Be patient during dose increases
Headaches are most common when your body is adjusting to each new dose.1
The standard schedule increases your dose every four weeks.
If headaches are particularly troublesome during this period, speak to your prescriber.
They may suggest staying at a lower dose for an extra two to four weeks before increasing, which gives your body more time to adjust.
Treating a headache when it happens
- Paracetamol is the safest first-line option and is compatible with Wegovy
- Ibuprofen can also be used, but take it with food to reduce stomach irritation (see our guide on painkillers while on Wegovy)
- Rest in a quiet room if possible
- A cold compress on the forehead or back of the neck can help
- Drink a glass of water; dehydration may be contributing
Eating well to reduce headache risk
Most headaches on Wegovy are linked to blood sugar fluctuations or dehydration. What you eat directly affects both.
Protein slows carbohydrate absorption, helping keep blood sugar more stable between meals.
Rapid drops in blood sugar are one of the most common headache triggers during dose increases, which is why protein at each meal helps.
- Prioritise protein at each meal: eggs, chicken, fish, lentils, tofu, Greek yoghurt
- Include complex carbohydrates for sustained energy: wholegrain or sourdough bread, oats, sweet potato, brown rice
- Include a source of healthy fat: extra-virgin olive oil, avocado, nuts, seeds, or oily fish. Fat slows stomach emptying further, which helps keep energy levels steady
- Don’t skip breakfast, even if it’s small. Something like porridge with berries and nuts or eggs on toast is enough.
- Try smaller portions with snacks in between if larger main meals are challenging to eat
- Keep hydrating foods accessible: cucumber, watermelon, soups, and smoothies all contribute to fluid intake
Staying active
Regular movement can help reduce headache frequency over time by improving circulation, reducing stress, and supporting sleep quality.
Getting started
The most important thing is building a habit you can sustain.
Research suggests that linking a new behaviour to an existing routine helps it become automatic.6
A short walk after a meal is a practical starting point, and you can gradually increase how much you do as it feels more comfortable.
When a headache limits what you can do
Gentle movement, like a slow walk or some stretching, is usually better than resting completely.
Low-intensity movement can help relieve tension headaches by releasing tightness in the neck and shoulders.
Avoid high-intensity exercise during an active headache as it increases blood pressure and can worsen the pain.
Once the headache passes, return to your usual activity.
Building up over time
Regular aerobic exercise can reduce migraine frequency over time.
A 2019 meta-analysis found that aerobic exercise reduced migraine days by around half a day per month on average. Effects on pain intensity were less clear, due to variation between studies.8
You don’t need to do anything extreme. Walking, swimming, or cycling at a moderate pace for 20 to 30 minutes, three to five times a week, is enough to see a benefit.
When to speak to your GP
Most headaches on Wegovy are mild and resolve on their own or with paracetamol. However, some headache patterns need medical attention.
Contact your GP if you experience:
- Headaches that don’t respond to over-the-counter painkillers
- Headaches lasting more than three days continuously
- A significant change in headache pattern or a new type of headache
- Headaches that worsen when lying down, coughing, or straining
- Headaches accompanied by persistent vomiting that prevents you from staying hydrated
- Feelings of anxiety or low mood related to your symptoms
Seek urgent medical attention (call 999 or go to A&E) if you experience:
- A sudden, severe headache that reaches maximum intensity within minutes
- Confusion, drowsiness, or difficulty speaking
- Visual disturbances (blurring, double vision, or loss of vision)
- Weakness or numbness, especially on one side of the body
- A headache with fever and stiff neck
These warning signs are not specific to Wegovy but apply to any new or severe headache.
Frequently asked questions
How long do headaches last on Wegovy?
Most headaches during dose increases are temporary and settle within a few days.
The STEP 5 trial showed that by two years, headache rates were identical between semaglutide and placebo, suggesting the excess headaches resolve as your body adjusts.3
Can I take paracetamol for headaches on Wegovy?
Yes. Paracetamol is safe and effective for managing headaches on Wegovy.
Research confirms that semaglutide doesn’t change the total amount of paracetamol your body absorbs, so standard dosing applies.
Are headaches a sign that Wegovy isn’t working?
No. Headaches aren’t an indicator of whether the medication is effective.
Many people achieve significant weight loss without experiencing headaches, and headaches don’t correlate with better or worse results.
Will headaches get worse at higher doses?
Headaches are most common during dose increases, generally, not specifically at higher doses.1
Each time you move to a new dose, there may be a brief adjustment period.
If headaches are persistent at a particular dose, your prescriber may suggest a slower schedule.
Should I stop Wegovy if I get headaches?
Don’t stop Wegovy without speaking to your prescriber first.
Headaches are usually temporary and manageable.
Stopping and restarting the medication means going through the dose increase process again, which could trigger the same side effects.
Do headaches mean I’m dehydrated?
Dehydration is one of the most common causes of headaches on Wegovy, but it isn’t the only one.
Changes in eating patterns, blood sugar fluctuations, caffeine withdrawal, and direct effects on the brain can all contribute.
If increasing your fluid intake doesn’t resolve the headache, other factors may be involved.
Can Wegovy trigger or worsen migraines?
For some people with existing migraines, dose increases can temporarily make migraine frequency worse, usually because of dehydration or changes in eating patterns.
For others, migraines improve over time as weight loss progresses, since obesity is itself a risk factor for chronic migraine.
If you have migraines, keep your usual prevention plan in place when starting Wegovy and speak to your GP or neurologist if your pattern changes significantly.
Is there a best time of day to inject Wegovy to avoid headaches?
There’s no published evidence on optimal injection timing for headache prevention.
Semaglutide’s effects build up gradually and remain steady throughout the week, rather than being tied to the day of injection.
If you notice a pattern with timing, discuss it with your prescriber.
Can Wegovy help with migraines?
Early research suggests GLP-1 receptor agonists may reduce migraine frequency in some people, possibly through effects on intracranial pressure.4
However, this research is preliminary, and semaglutide isn’t licensed for migraine treatment.
Are headaches more common on Wegovy than other weight loss medications?
The Wegovy prescribing information classifies headache as ‘common’ (affecting 1-10% of people).1
Headache rates are broadly similar across GLP-1 receptor agonists, including tirzepatide.
They’re less common than gastrointestinal side effects like nausea, which affect over 40% of people.
Can I get Wegovy on the NHS?
Yes. NICE recommends semaglutide for weight management in eligible adults (TA875).
Your GP can refer you to a specialist weight management service. Experiencing headaches doesn’t affect your eligibility.
Take home message
Headaches on Wegovy are common but usually temporary.
They affect around 14% of people in clinical trials, mainly during dose increases, and resolve as your body adjusts to the medication.2
Most headaches are caused by dehydration, changes in eating patterns, blood sugar fluctuations, or caffeine withdrawal.
Staying well hydrated, eating regular meals with protein, avoiding sudden changes in caffeine intake, and being patient during dose increases are the most effective ways to prevent them.
Two-year data show that headache rates eventually become identical to placebo.3
If headaches are severe, persistent, or accompanied by symptoms like visual changes or confusion, seek medical attention promptly.
Second Nature’s programme combines medication support with personalised nutrition guidance from registered dietitians and nutritionists, built around a balanced plate of vegetables, protein, complex carbohydrates, and healthy fats.
A peer-reviewed study published in JMIR Formative Research found that participants on Second Nature’s semaglutide-supported programme lost an average of 17.1% of their body weight at 12 months.7
Second Nature's Mounjaro and Wegovy programmes
Second Nature provides Mounjaro or Wegovy as part of our Mounjaro and Wegovy weight-loss programmes.
Why choose Second Nature over other medication providers, assuming you're eligible?
Because peace of mind matters.
We've had the privilege of working with the NHS for over eight years, helping people across the UK take meaningful steps toward a healthier, happier life.
Our programmes are designed to meet people where they are, whether that means support with weight loss through compassionate one-to-one health coaching, or access to the latest weight-loss medications (like Mounjaro and Wegovy) delivered alongside expert care from a multidisciplinary team of doctors, psychologists, dietitians, and personal trainers.
At the heart of everything we do is a simple belief: real, lasting change comes from building better habits, not relying on quick fixes. We're here to support that change every step of the way.
With over a decade of experience, thousands of lives changed, and a long-standing record of delivering programmes used by the NHS, we believe we're the UK's most trusted weight-loss programme.
We hope to offer you something invaluable: peace of mind, and the support you need to take that first step.
References
- Electronic Medicines Compendium. (2026). Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen: Summary of Product Characteristics.
- Wilding, J.P.H. et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.
- Garvey, W.T. et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28, 2083-2091.
- Ferreira, E.T. et al. (2025). Headache and GLP-1 receptor agonists: when medications are therapeutic and when they contribute to the symptom. Arquivos de Neuro-Psiquiatria.
- Wharton, S. et al. (2022). Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity. Diabetes, Obesity and Metabolism, 24(1), 94-105.
- Lally, P. et al. (2010). How are habits formed: modelling habit formation in the real world. European Journal of Social Psychology, 40(6), 998-1009.
- Richards, R. et al. (2025). Semaglutide and tirzepatide in a remote weight management program: 12-month retrospective observational study. JMIR Formative Research, 9, e81912.
- Lemmens, J. et al. (2019). The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis. The Journal of Headache and Pain, 20(1), 16.
